Enhabit, Inc. (EHAB) Q2 2025 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Barbara Ann Jacobsmeyer - President, CEO & Director Bob Okunski - Corporate Participant Ryan T. Solomon - Chief Financial Officer Conference Call Participants Albert J.
Enhabit (EHAB) Beats Q2 Earnings and Revenue Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.07 per share a year ago.
All You Need to Know About Enhabit (EHAB) Rating Upgrade to Buy
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Enhabit, Inc. (EHAB) Q1 2025 Earnings Call Transcript
Start Time: 10:00 January 1, 0000 10:27 AM ET Enhabit, Inc. (NYSE:EHAB ) Q1 2025 Earnings Conference Call May 08, 2025, 10:00 AM ET Company Participants Barb Jacobsmeyer - President and CEO Ryan Solomon - CFO Jobie Williams - SVP and Treasurer Conference Call Participants Brian Tanquilut - Jefferies AJ Rice - UBS Ryan Langston - TD Cowen Whit Mayo - Leerink Partners Operator Hello. Good morning, everyone, and welcome to Enhabit Home Health & Hospice's First Quarter 2025 Earnings Conference Call.
Enhabit (EHAB) Q1 Earnings Top Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Here is how Enhabit (EHAB) and Doximity (DOCS) have performed compared to their sector so far this year.
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Enhabit, Inc. (EHAB) Q4 2024 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q4 2024 Results Conference Call March 6, 2025 10:00 AM ET Company Participants Jobie Williams - Senior Vice President and Treasurer Barb Jacobsmeyer - President and Chief Executive Officer Ryan Solomon - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Ryan Langston - TD Cowen Operator Hello, and welcome to the Enhabit Inc. Fourth Quarter 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Jobie Williams, Enhabit's Senior Vice President and Treasurer.
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate substantial upside potential in stock price.
